Vemurafenib-induced nonautoimmune haemolytic anaemia

Melanoma Res. 2014 Aug;24(4):418-9. doi: 10.1097/CMR.0000000000000094.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Hemolytic / chemically induced*
  • Humans
  • Indoles / administration & dosage
  • Indoles / adverse effects*
  • Male
  • Melanoma / drug therapy
  • Middle Aged
  • Sulfonamides / administration & dosage
  • Sulfonamides / adverse effects*
  • Vemurafenib

Substances

  • Indoles
  • Sulfonamides
  • Vemurafenib